Enquire

SENSE / UNDERSTAND / RESTORE

HUMAN
INTELLIGENCE.
ANYWHERE.

Building a deeper understanding of the nervous system. Developing the instruments to read it, support it, and restore what has been lost.

Explore Sentinel

BUILT ON CURIOSITY.
A WIDER TOMORROW.

DISCOVER PHANES 01 / 04

01 / OUR TECHNOLOGY

From understanding to possibility.

Infrastructure for
the nervous system.

Connected platforms. One shared ambition.

We are developing a family of neurotechnology platforms around a common foundation of electrode materials and decoding software. Our work begins with Sentinel: continuous EEG for clinical care. VITAL extends our research to whole-body physiology through a distinct sensing platform.

02 / SENTINEL

CLINICAL EEG · IN DEVELOPMENT

More time.
More understanding.

Brain activity unfolds over time. Sentinel is being designed for continuous, multi-day EEG monitoring, bringing raw signals, marked events and clinical context into one workspace.

SENTINEL / CLINICAL WORKSPACE
01 — Clinical review & marked eventsConcept visualisation · Illustrative data
01

Continuity by design

A development focus on longer recordings, comfortable contact and the practical demands of monitoring at the bedside.

02

Clinical context, together

A proposed workspace for EEG traces, annotations and notes, designed to support the clinician’s review.

03

Intelligence at the edge

Exploring on-device analysis to support a privacy-conscious architecture and reduce reliance on continuous cloud processing.

Sentinel is in development. These concepts do not represent a clinically validated or cleared medical device.

VITAL / WHOLE-BODY PHYSIOLOGICAL INTELLIGENCE

DESIGN STAGE

One body.
A lifetime of context.

The device is the entry point.
The longitudinal model is the ambition.

VITAL is being designed to learn how an individual responds, adapts and recovers over time. A reusable sensing core and interchangeable mounts would connect physiological signals with activity and environment.

Sentinel focuses on the brain. VITAL focuses on the body. They are separate platforms, with a future ambition to connect their insights.

01 / SENSE

One core. Many mounts.

The proposed core brings together single-lead ECG, movement, skin temperature and contact quality, with respiration derived from chest motion and electrodermal activity interpreted in context.

02 / CONTEXTUALISE

Understand the individual.

Research into personal baselines, meaningful changes and confidence in the evidence. The aim is to remain quiet when variation is normal.

03 / LEARN

Begin with performance.

Initial intended applications are elite sport and human performance research. Broader environments follow evidence from the first deployments.

VITAL is at the design stage. Hardware, modelling and performance remain to be validated. Optical pulse and oxygen-saturation sensing are under evaluation, not committed capabilities.

03 / APPLICATIONS

A sequenced ambition.

Begin where the need
is closest.

Our clinical focus is neuromonitoring. Alongside it, VITAL explores physiological intelligence for elite sport and human performance research.

The science behind our approach
01 Neuro-intensive care +

Sentinel’s initial development focus: continuous EEG at the bedside, with tools intended to help clinicians review brain activity over time.

02 Hospital to home +

A later ambition for an ambulatory Sentinel platform: longer-duration recording outside hospital. Development, validation and the care pathway remain to be established.

03 Sensing prosthetics +

Touch explores prosthetic control and sensory feedback, including information about contact and slip. The programme is at the research and architecture stage.

04 Hearing restoration +

Lucid is a research direction in hearing restoration. It is part of the longer-term portfolio, rather than an available or clinically validated product.

05 Human performance +

VITAL’s proposed entry points are elite sport and human performance research: learning individual physiological baselines and investigating responses to training, workload and recovery.

04 / OUR SCIENTIFIC APPROACH

Ambition asks.
Evidence answers.

Progress is something we demonstrate.

Our development approach is built around testing assumptions early, protecting sensitive neural data and designing with clinical use in mind.

01 Test the foundations

02 Validate on our own hardware

03 Build the clinical evidence

Prototype validation and regulatory assessment are milestones ahead of us, not claims of work already completed.

PEOPLE / THE FOUNDING TEAM

Building Phanes together.

Curiosity, with direction.

FOUNDER & CEO

Kahi
Bradshaw-Williams

CO-FOUNDER & CTO

Michael
Yang

PHANES INSTRUMENTS / UNITED KINGDOM

Make humanity
more.

We are an early-stage neurotechnology venture building towards a future in which better understanding of the nervous system expands what people can do.

Discover our platforms

CONTACT / START A CONVERSATION

What could we
build together?

For research collaborations, clinical partnerships and enquiries about our work.

Email Kahibw@phanesneuro.tech, or use the form to prepare your enquiry.

Opens a draft in your email app. Review it and press Send there. This website does not store your message.

Enlarged Sentinel interface concept

Concept visualisation. Illustrative data; not for clinical use.